Provided by Tiger Trade Technology Pte. Ltd.

Warrior Met Coal LLC

97.77
-3.8800-3.82%
Post-market: 97.770.00000.00%16:15 EDT
Volume:613.54K
Turnover:60.34M
Market Cap:5.14B
PE:23.50
High:103.45
Open:102.10
Low:96.00
Close:101.65
52wk High:111.42
52wk Low:57.53
Shares:52.57M
Float Shares:51.78M
Volume Ratio:1.58
T/O Rate:1.19%
Dividend:0.32
Dividend Rate:0.33%
EPS(TTM):4.16
EPS(LYR):1.08
ROE:10.04%
ROA:5.17%
PB:2.24
PE(LYR):90.53

Loading ...

Warrior Met Coal (HCC) Updates 2026 Guidance, Is It Still Below Fair Value?

Simply Wall St.
·
Aug 09

Alpha Metallurgical Q2 Adjusted Ebitda Misses Estimates on Lower Shipments

Reuters
·
Aug 07

Warrior Met Coal Price Target Cut to $98.00/Share from $100.00 by UBS

Dow Jones
·
Aug 07

UBS Adjusts Warrior Met Coal Price Target to $98 From $100, Maintains Buy Rating

MT Newswires Live
·
Aug 06

Analysts Offer Insights on Materials Companies: Linde (LIN), Warrior Met Coal (HCC) and Hudson Tech (HDSN)

TIPRANKS
·
Aug 06

Analysts Offer Insights on Materials Companies: TRONOX (TROX), Westlake Corporation (WLK) and Warrior Met Coal (HCC)

TIPRANKS
·
Aug 06

Core Natural Resources Q2 Ebitda Beats Estimates

Reuters
·
Aug 06

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals

GlobeNewswire
·
Aug 06

Warrior Met Coal Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Warrior Met Coal Q2 Revenue Jumps 71% as Blue Creek Mine Boosts Volumes

Reuters
·
Aug 06

Warrior Met Coal Q2 Net Income USD 87.4 Million

Reuters
·
Aug 06

Warrior Met Coal Q2 EPS $1.65 Beats $1.55 Estimate, Sales $509.690M Beat $488.358M Estimate

Benzinga Earnings
·
Aug 06

Warrior Met Coal - Full Year 2026 Coal Sales Guidance 13.0-14.0 Mln Short Tons

THOMSON REUTERS
·
Aug 06

Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome

GlobeNewswire
·
Aug 03

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise

GlobeNewswire
·
Aug 03

Earning Preview: Warrior Met Coal LLC this quarter’s revenue is expected to increase by 66.90%, and institutional views are bullish

Earnings Agent
·
Jul 29

Warrior Met Coal Keeps Quarterly Dividend at $0.08 a Share, Payable Aug. 17 to Holders of Record Aug. 10

MT Newswires Live
·
Jul 29

Press Release: Warrior Announces Regular Quarterly Cash Dividend

Dow Jones
·
Jul 29

Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC

GlobeNewswire
·
Jul 22

Coal Sector Urges Trump Administration to Provide Financing for Existing, New Power Plants

Reuters
·
Jul 22